Published in Int J STD AIDS on November 01, 2000
Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull (2004) 8.52
Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med (2008) 1.27
Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS (2014) 0.95
Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load. J Assoc Nurses AIDS Care (2014) 0.78
Effectiveness of Psycho-Educational Intervention in HIV Patients' Treatment. Front Psychiatry (2015) 0.77
Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clin Psychol Rev (2016) 0.75
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (2000) 3.66
HIV and surgeons. BMJ (1990) 2.81
Investigation of the effects of coffee on alertness and performance during the day and night. Neuropsychobiology (1993) 2.62
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet (1974) 2.37
Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis (2005) 2.36
Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut (1996) 2.26
Transmission of human immunodeficiency virus by heterosexual contact with reference to antenatal screening. Br J Obstet Gynaecol (1989) 2.22
The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT) Q J Med (1993) 2.15
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Patient preferences for single rooms or shared accommodation in a district general hospital. Scott Med J (2009) 2.08
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol (2005) 2.07
Reversible renal failure caused by a microsporidian infection. AIDS (1994) 2.07
Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet (1974) 1.97
Why do people use paracetamol for suicide? Br Med J (1976) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med (1975) 1.82
The social toll of Crohn's disease. Br Med J (1978) 1.80
Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS (1998) 1.74
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS (1994) 1.70
Relationship between CD4 count and CD4% in HIV-infected people. Int J Epidemiol (1997) 1.67
Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS (1992) 1.65
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Thrombocytopenia in hypothermia: a common but poorly recognised complication. Br Med J (Clin Res Ed) (1985) 1.61
Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. J Hosp Infect (2000) 1.56
Psychiatric patients and HIV infection: a new population at risk? Br J Psychiatry (1995) 1.55
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut (1995) 1.54
Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood (2000) 1.52
Microsporidiosis in HIV-1-infected individuals. Lancet (1991) 1.50
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Controlled trial of cysteamine and dimercaprol after paracetamol overdose. Br Med J (1977) 1.45
Cerebral abscesses in a patient with AIDS caused by methicillin-resistant Staphylococcus aureus (MRSA) Int J STD AIDS (1997) 1.45
Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS (1992) 1.45
The health of children in Kisarawe District, Tanzania. Trop Geogr Med (1969) 1.45
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Lancet (1991) 1.44
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. J Infect (2001) 1.43
Exercise responses and psychiatric disorder in chronic fatigue syndrome. BMJ (1995) 1.43
Cryptosporidial diarrhoea in AIDS and its treatment. Gut (1988) 1.42
Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol (1994) 1.39
Superbugs: are we at the threshold of a new Dark Age? Hosp Med (1998) 1.39
Strategies to inhibit alloantibody production in alloprimed murine recipients of hematopoietic stem cell grafts. Am J Transplant (2015) 1.39
The use of text messaging to reduce non-attendance at outpatients clinic--a departmental experience. Ir Med J (2011) 1.38
Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut (1989) 1.32
Lateral sinus thrombosis and intracranial hypertension in essential thrombocythaemia. J Neurol Neurosurg Psychiatry (1986) 1.32
Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut (1989) 1.31
Cryptosporidiosis in HIV-seropositive patients. Q J Med (1993) 1.30
Intestinal inflammation, ileal structure and function in HIV. AIDS (1996) 1.29
Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat Res (1995) 1.29
Dupuytren's contractures in patients infected with HIV. BMJ (1990) 1.28
Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis (1995) 1.27
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Lancet (1984) 1.26
Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care (2001) 1.26
Pseudomonas septicaemia associated with HIV. AIDS (1991) 1.24
Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS (1993) 1.24
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Med (2005) 1.22
Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy. J Antimicrob Chemother (1994) 1.22
Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM (2010) 1.19
Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team. AIDS (1998) 1.18
Recurrent Helicobacter cinaedi cellulitis and bacteraemia in a patient with HIV Infection. Int J STD AIDS (1997) 1.16
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med (2005) 1.16
A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Br J Cancer (1989) 1.15
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection. Eur J Immunol (2001) 1.14
Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol (2002) 1.13
Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. J Clin Pathol (1997) 1.11
Histological diagnosis of intestinal microsporidiosis in patients with AIDS. J Clin Pathol (1991) 1.11
Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis (1999) 1.11
The pharmacokinetics of oral itraconazole in AIDS patients. J Pharm Pharmacol (1992) 1.10
Fibrinogen metabolism in acute hepatitis and active chronic hepatitis. Br J Haematol (1975) 1.10
Disorderd hemostasis in liver damage from paracetamol overdose. Gastroenterology (1973) 1.10
Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1. Gut (1990) 1.09
Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS (1998) 1.09
Streptobacillus moniliformis isolated from blood in four cases of Haverhill fever. Lancet (1983) 1.08
Fibreoptic bronchoscopy in diagnosis of bronchopulmonary Kaposi's sarcoma. Thorax (1987) 1.08
DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med (1993) 1.07
Simultaneous infection with two types of intestinal microsporidia in a patient with AIDS. Gut (1992) 1.07
Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients. Antimicrob Agents Chemother (1992) 1.07
Photoinduced double proton transfer in a model hydrogen bonded base pair. Theoretical study. J Theor Biol (1979) 1.06
Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgrad Med J (1977) 1.06
Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure. Gut (1974) 1.06
The binding of paracetamol to plasma proteins of man and pig. J Pharm Pharmacol (1973) 1.06
Fourniers gangrene following hyfrecation in a male infected with the human immunodeficiency virus. Genitourin Med (1992) 1.05
Reversible bronchoconstriction with nebulised pentamidine. Lancet (1988) 1.05
A unique radiological pentad of mesonephric duct abnormalities in a young man presenting with testicular swelling. Br J Radiol (2008) 1.05
Investigation of upper gastrointestinal symptoms in patients with AIDS. AIDS (1989) 1.05
The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. Gut (1975) 1.04
Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med (2006) 1.04
Sexual Risk Cognitions Questionnaire: a reliability and validity study. AIDS Care (1997) 1.04
Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study. Br J Ophthalmol (1999) 1.03
Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med (1999) 1.03